ArticleHaematologica2017
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial.
Yasuhiro Oki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this papertrialcites it